Telmisartan information

Telmisartan
Clinical data
Pronunciation	/tɛlmɪˈsɑːrtən/
Trade names	Micardis, Actavis, others
AHFS/Drugs.com	Monograph
MedlinePlus	a601249
License data	US DailyMed: Telmisartan;
Pregnancy; category	AU: D; ;
Routes of; administration	By mouth
Drug class	Angiotensin II receptor antagonist
ATC code	C09CA07 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); CA: ℞-only; UK: POM (Prescription only); US: WARNINGRx-only; EU: Rx-only;
Pharmacokinetic data
Bioavailability	42–100%
Protein binding	>99.5%
Metabolism	Minimal liver (glucuronidation)
Elimination half-life	24 hours
Excretion	Feces 97%
Identifiers
	IUPAC name 2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid;
CAS Number	144701-48-4 ;
PubChem CID	65999;
IUPHAR/BPS	592;
DrugBank	DB00966 ;
ChemSpider	59391 ;
UNII	U5SYW473RQ;
KEGG	D00627 ;
ChEBI	CHEBI:9434 ;
ChEMBL	ChEMBL1017 ;
CompTox Dashboard (EPA)	DTXSID8023636 ;
ECHA InfoCard	100.149.347
Chemical and physical data
Formula	C33H30N4O2
Molar mass	514.629 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(O)c1ccccc1c2ccc(cc2)Cn3c4cc(cc(c4nc3CCC)C)c5nc6ccccc6n5C;
	InChI InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39) ; Key:RMMXLENWKUUMAY-UHFFFAOYSA-N ;
	(verify)

Telmisartan, sold under the brand name Micardis among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease.^[2] It is a reasonable initial treatment for high blood pressure.^[2] It is taken by mouth.^[2] Versions are available as the combination^[3] telmisartan/hydrochlorothiazide, telmisartan/cilnidipine^[4] and telmisartan/amlodipine.^[2]

Common side effects include upper respiratory tract infections, diarrhea, and back pain.^[2] Serious side effects may include kidney problems, low blood pressure, and angioedema.^[2] Use in pregnancy may harm the baby and use when breastfeeding is not recommended.^[5] It is an angiotensin II receptor antagonist and works by blocking the effects of angiotensin II.^[2]

Telmisartan was patented in 1991 and came into medical use in 1999.^[6] It is available as a generic medication.^[7] In 2021, it was the 217th most commonly prescribed medication in the United States, with more than 1 million prescriptions.^[8]^[9]

^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.
^ ^a ^b ^c ^d ^e ^f ^g "Telmisartan Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 3 March 2019.
^ Golwala D. "Formulation and Evaluation of Mouth Dissolving Tablets of Telmisartan". Inventi Journals. Retrieved 18 July 2020.^{[permanent dead link]}
^ "Cilacar T". Medical Dialogues. Retrieved 23 February 2021.
^ "Telmisartan Pregnancy and Breastfeeding Warnings". Drugs.com. Retrieved 3 March 2019.
^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 471. ISBN 9783527607495.
^ British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 178. ISBN 9780857113382.
^ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
^ "Telmisartan - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.

[FDA-AllBoxedWarnings-1] "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.

[AHFS2019-2] ^ ^a ^b ^c ^d ^e ^f ^g "Telmisartan Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 3 March 2019.

[3] Golwala D. "Formulation and Evaluation of Mouth Dissolving Tablets of Telmisartan". Inventi Journals. Retrieved 18 July 2020.^{[permanent dead link]}

[4] "Cilacar T". Medical Dialogues. Retrieved 23 February 2021.

[Preg2019-5] "Telmisartan Pregnancy and Breastfeeding Warnings". Drugs.com. Retrieved 3 March 2019.

[Fis2006-6] Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 471. ISBN 9783527607495.

[BNF76-7] British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 178. ISBN 9780857113382.

[8] "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.

[9] "Telmisartan - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.

Telmisartan information

and 26 Related for: Telmisartan information

Telmisartan

WHO Model List of Essential Medicines

Angiotensin II receptor blocker

Ramipril

ATC code C09

Boehringer Ingelheim

Benzimidazole

Amlodipine

Discovery and development of angiotensin receptor blockers

Losartan

Biphenyl

Perindopril

Erythromycin

GW501516

Kinzhal

Fenbendazole

List of veterinary drugs

Fentanyl

Tetrahydrocannabinol

Hypericum perforatum

Irbesartan

Flucloxacillin

Valsartan

Clotrimazole

Lisinopril

List of cardiac pharmaceutical agents